Cargando…

The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)

BACKGROUND: Urinary system resections are performed during the cytoreductive surgery with hypertermic intraperitoneal chemotherapy (CRS-HIPEC). However, isolated ureter resection and reconstruction results are uncertain. The aim of this study was to evaluate the postoperative outcomes of isolated ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Morkavuk, Şevket Barış, Güner, Murat, Tez, Mesut, Ünal, Ali Ekrem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933878/
https://www.ncbi.nlm.nih.gov/pubmed/31878943
http://dx.doi.org/10.1186/s12957-019-1770-x
_version_ 1783483294444158976
author Morkavuk, Şevket Barış
Güner, Murat
Tez, Mesut
Ünal, Ali Ekrem
author_facet Morkavuk, Şevket Barış
Güner, Murat
Tez, Mesut
Ünal, Ali Ekrem
author_sort Morkavuk, Şevket Barış
collection PubMed
description BACKGROUND: Urinary system resections are performed during the cytoreductive surgery with hypertermic intraperitoneal chemotherapy (CRS-HIPEC). However, isolated ureter resection and reconstruction results are uncertain. The aim of this study was to evaluate the postoperative outcomes of isolated ureteral resection and reconstructions in patients who underwent CRC and HIPEC procedure. METHODS: A total of 257 patients that underwent CRC and HIPEC between 2015 and 2017 in the Department of Surgical Oncology, Faculty of Medicine, Ankara University, were retrospectively analyzed. Twenty patients that had undergone isolated ureteral resection and reconstruction were included in the study. Predisposing factors were investigated in patients who developed postoperative complications. RESULTS: The mean age of the patients was 55.1 years. The mean follow-up time of all the patients was 11.6 months. Postoperative mortality occurred in two patients. The mean PCI score was 13.9. Postoperative urologic complications were observed in eight patients after ureter reconstruction. There was no statistically significant difference between the groups in terms of reconstruction techniques and postoperative complications (P = 302). There was no correlation between age (P = 0.571) and gender (P = 0.161) with complications. CRS-HIPEC was performed mostly due to gynecologic malignancy. However, there was no correlation between the primary cancer diagnosis and the development of complications (P = 0.514). The hospital stay duration was higher in the group with complications (16.3 vs 8.8 days, P = 0.208). CONCLUSIONS: Ureteral resections and reconstructions can be performed for R0/1 resections in CRS-HIPEC operations. It leads to an increase in hospital stay. But there is no significant difference in the development of complications. In the management of complications, conservative approach was sufficient.
format Online
Article
Text
id pubmed-6933878
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69338782019-12-30 The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) Morkavuk, Şevket Barış Güner, Murat Tez, Mesut Ünal, Ali Ekrem World J Surg Oncol Research BACKGROUND: Urinary system resections are performed during the cytoreductive surgery with hypertermic intraperitoneal chemotherapy (CRS-HIPEC). However, isolated ureter resection and reconstruction results are uncertain. The aim of this study was to evaluate the postoperative outcomes of isolated ureteral resection and reconstructions in patients who underwent CRC and HIPEC procedure. METHODS: A total of 257 patients that underwent CRC and HIPEC between 2015 and 2017 in the Department of Surgical Oncology, Faculty of Medicine, Ankara University, were retrospectively analyzed. Twenty patients that had undergone isolated ureteral resection and reconstruction were included in the study. Predisposing factors were investigated in patients who developed postoperative complications. RESULTS: The mean age of the patients was 55.1 years. The mean follow-up time of all the patients was 11.6 months. Postoperative mortality occurred in two patients. The mean PCI score was 13.9. Postoperative urologic complications were observed in eight patients after ureter reconstruction. There was no statistically significant difference between the groups in terms of reconstruction techniques and postoperative complications (P = 302). There was no correlation between age (P = 0.571) and gender (P = 0.161) with complications. CRS-HIPEC was performed mostly due to gynecologic malignancy. However, there was no correlation between the primary cancer diagnosis and the development of complications (P = 0.514). The hospital stay duration was higher in the group with complications (16.3 vs 8.8 days, P = 0.208). CONCLUSIONS: Ureteral resections and reconstructions can be performed for R0/1 resections in CRS-HIPEC operations. It leads to an increase in hospital stay. But there is no significant difference in the development of complications. In the management of complications, conservative approach was sufficient. BioMed Central 2019-12-26 /pmc/articles/PMC6933878/ /pubmed/31878943 http://dx.doi.org/10.1186/s12957-019-1770-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Morkavuk, Şevket Barış
Güner, Murat
Tez, Mesut
Ünal, Ali Ekrem
The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_full The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_fullStr The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_full_unstemmed The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_short The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
title_sort outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (crc) and hyperthermic intraperitoneal chemotherapy (hipec)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933878/
https://www.ncbi.nlm.nih.gov/pubmed/31878943
http://dx.doi.org/10.1186/s12957-019-1770-x
work_keys_str_mv AT morkavuksevketbarıs theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT gunermurat theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT tezmesut theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT unalaliekrem theoutcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT morkavuksevketbarıs outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT gunermurat outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT tezmesut outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec
AT unalaliekrem outcomesofisolatedureteralresectionandreconstructioninnonurologiccancerpatientswhounderwentcytoreductivesurgerycrcandhyperthermicintraperitonealchemotherapyhipec